Ebola Vaccine Will Now Be Available As Gavi Signed $5 Million Deal To Prevent Future Outbreaks, Commits Merck To Keep 300,000 Vaccines Ready

Gavi, a world vaccine alliance, has made a $5 million deal with Merck regarding vaccine supply for future outbreaks. Merck has to provide 300,000 vaccines as a preparation to protect people from the next Ebola crisis.

Read Full Article

Russia Created Vaccine For Ebola Virus Treatment: Vladimir Putin, Drawing Cynicism From Experts

The president of Russia, Vladimir Putin, announced that his country had found two vaccines to cure Ebola. However, the announcement has drawn some skepticism among experts who have previously developed other vaccines for Ebola.

Read Full Article

U.S. companies face billions in Venezuela currency losses, Reuters analysis shows

At least 40 major U.S. companies have substantial exposure to Venezuela’s deepening economic crisis, and could collectively be forced to take billions of dollars of write downs, a Reuters analysis shows.

Read Full Article

Merck to take on superbugs with Cubist Pharma buy

Merck & Co Inc (MRK.N) said it would buy Cubist Pharmaceuticals Inc (CBST.O) for $8.4 billion plus assumption of debt, giving the major drugmaker an entry into the market for drugs that combat so-called superbugs.

Read Full Article

Germany's Merck aims to grow, not sell $1 billion consumer health arm

Merck KGaA (MRCG.DE) aims to keep hold of its consumer healthcare unit, it said on Friday, pledging to develop a business that is expected to generate 2014 sales of $1 billion for the German drugs and chemicals company.

Read Full Article

Merck buys rights to NewLink's experimental Ebola vaccine

Merck & Co Inc (MRK.N) on Monday said it would buy worldwide commercial rights to NewLink Genetics Corp's (NLNK.O) experimental vaccine against the Ebola virus.

Read Full Article

Merck strikes €20m deal with Ablynx for new generation cancer drugs

Ablynx, a Belgian biotechnology firm, has agreed to a €20 million deal with Merck to develop immunotherapies that can bolster the human body's potential to combat cancer cells, the Financial Times reported.

Read Full Article

UK's AZ Electronics shareholder rejects Merck takeover bid

UK asset manager Threadneedle Investments has increased its stake in AZ Electronic Materials to above 11% in a move that could block the GBP1.56 billion takeover bid from German drugmaker Merck.

Read Full Article

Germany's Merck looks for deals to lift U.S. drug sales

German healthcare group Merc is looking for acquisitions and collaborations with start-ups to grow its drugs business in the United States, a senior Merck official said.

Read Full Article

Akorn grabs 3 eye drop products from Merck

Illinois-based niche pharmaceutical firm Akorn Inc acquired the US rights to three branded ophthalmic products from New Jersey-based international pharmaceutical company Merck for USD52.8 million.

Read Full Article

Merck and Pfizer Announce Deal

Merck and Pfizer announce deal for the inclusion of ertugliflozin into current diabetes drug portfolios of the companies.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics